Page last updated: 2024-09-02

2-acetyl-4(5)-tetrahydroxybutylimidazole and MS (Multiple Sclerosis)

2-acetyl-4(5)-tetrahydroxybutylimidazole has been researched along with MS (Multiple Sclerosis) in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beerli, C; Bergsdorf, C; Billich, A; Braendlin, N; Oberhauser, B; Schubart, A; Srinivas, H; Weiler, S1

Other Studies

1 other study(ies) available for 2-acetyl-4(5)-tetrahydroxybutylimidazole and MS (Multiple Sclerosis)

ArticleYear
Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis.
    Journal of medicinal chemistry, 2014, Jun-26, Volume: 57, Issue:12

    Topics: Administration, Oral; Aldehyde-Lyases; Animals; Catalytic Domain; Cells, Cultured; Crystallography, X-Ray; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Male; Models, Molecular; Multiple Sclerosis; Mutation; Phthalazines; Protein Conformation; Pyridines; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship

2014